A Canadian Randomized Controlled Trial of DMARD Withdrawal in RA Patients Achieving Therapeutic Response With Cimzia + DMARD Combination Treatment
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Certolizumab pegol (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 17 Jun 2017 Results (n=121) presented at the 18th Annual Congress of the European League Against Rheumatism
- 12 Apr 2017 Planned End Date changed from 1 Jul 2014 to 1 Sep 2018.
- 12 Apr 2017 Planned primary completion date changed from 1 Jun 2014 to 27 Aug 2018.